|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Bad Debt Expense | |||||
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to net loss: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Goodwill impairment | |||||
| Inventory impairments through costs of sales | |||||
| Other asset impairments | |||||
| Changes in fair value of digital assets | |||||
| Changes in financial instruments at fair value | |||||
| Settlement of contingent consideration | |||||
| Realized gain on settlement of convertible note | |||||
| Bad debt expense | |||||
| Loss on fixed asset disposals | |||||
| Loss on disposal of discontinued operations | |||||
| Gain on disposal of Insolvent Entities | |||||
| Derecognition of equity related to insolvent subsidiaries | |||||
| Interest expense, net | |||||
| Income tax expense (benefit) | |||||
| Interest paid | |||||
| Income tax benefit | |||||
| Net income (loss) to cash provided by (Used in) operating activities | |||||
| Net change in non-cash working capital: | |||||
| Trade and other receivables | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Trade payables and accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from financing activities: | |||||
| Equity issued | |||||
| Equity issue costs | |||||
| Exercise of warrants and options | |||||
| Common shares repurchased | |||||
| Payment for settlement of contingent consideration | |||||
| Settlement of convertible note | |||||
| Loan borrowings | |||||
| Loan repayments | |||||
| Net cash provided by financing activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of digital assets | |||||
| Sale of digital assets | |||||
| Net cash on cannabis business disposal | |||||
| Purchases of property, plant and equipment and intangible assets | |||||
| Net cash on insolvency | |||||
| Net cash on asset disposals | |||||
| Business and asset acquisitions, net of cash acquired | |||||
| Net cash (used) provided in investing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Change in cash for the year | |||||
| Cash and restricted cash at beginning of period | |||||
| Cash included in assets held for sale | |||||
| Cash and restricted cash at end of year | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Common shares issued for other agreements | |||||
| Intangible assets acquired for contingent consideration | |||||
| Equity issued for digital assets | |||||
| Debt issued for digital assets | |||||
| Digital assets used to settle convertible note | |||||
| Debt issued for business combinations | |||||
| Operating lease additions to right of use assets | |||||
| Common shares issued for business combinations | |||||
| Shares issued to settle convertible note | |||||
| ELOC commitment fee | |||||
| Option cancellations reclassified to equity | |||||
Loading...